A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma

Clinical trial NCT02514668 · COMPLETED

Trial details

NCT number: NCT02514668
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Plasma Cell Myeloma

Start date: 2015-09-01
Primary completion: 2021-12-02
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.